SHI Yushuang,WANG Huihua,LI Yan, et al. Analysis of the Effectiveness of Different Atrial Fibrillation Screening Methods in the Community-based Elderly Population[J]. Chinese General Practice, 2024, 27(11): 1316-1319. DOI: 10.12114/j.issn.1007-9572.2023.0723.
石玉霜,王惠华,李艳等. 不同心房颤动筛查方式在社区老年人中的效果研究[J]. 中国全科医学, 2024, 27(11): 1316-1319. DOI: 10.12114/j.issn.1007-9572.2023.0723.
SIUC W,LIPG Y,LAMK F,et al. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong[J]. Heart Rhythm2014,11(8):1401-1408. DOI:10.1016/j.hrthm.2014.04.021.
[3]
HERMANSA N L,GAWALKOM,DOHMENL,et al. Mobile health solutions for atrial fibrillation detection and management:a systematic review[J]. Clin Res Cardiol,2022,111(5):479-491. DOI:10.1007/s00392-021-01941-9.
[4]
GUOY T,WANGH,ZHANGH,et al. Mobile photoplethysmographic technology to detect atrial fibrillation[J]. J Am Coll Cardiol,2019,74(19):2365-2375. DOI:10.1016/j.jacc.2019.08.019.
MASONP K,LAKED E,DIMARCOJ P,et al. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation[J]. Am J Med,2012,125(6):603.e1-603.e6. DOI:10.1016/j.amjmed.2011.09.030.
[8]
GIBBSH,FREEDMANB,ROSENQVISTM,et al. Clinical outcomes in asymptomatic and symptomatic atrial fibrillation presentations in GARFIELD-AF:implications for AF screening[J]. Am J Med,2021,134(7):893-901.e11. DOI:10.1016/j.amjmed.2021.01.017.
[9]
SGRECCIAD,MANICARDIM,MALAVASIV L,et al. Comparing outcomes in asymptomatic and symptomatic atrial fibrillation:a systematic review and meta-analysis of 81,462 patients[J]. J Clin Med,2021,10(17):3979. DOI:10.3390/jcm10173979.
[10]
ARONSSONM,SVENNBERGE,ROSENQVISTM,et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording[J]. Europace,2015,17(7):1023-1029. DOI:10.1093/europace/euv083.
[11]
KIRCHHOFP,BENUSSIS,KOTECHAD,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962. DOI:10.1093/eurheartj/ehw210.
[12]
HINDRICKSG,POTPARAT,DAGRESN,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) Developed with the special contribution of the European Heart Rhythm Association(EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498. DOI:10.1093/eurheartj/ehaa612.
[13]
PÉRULA-DE TORRESL A,LUQUE-MONTILLAR,et al. Validation of taking arterial pulse in Primary Care for the detection of atrial fibrillation and other cardiac rhythm disorders in patients over 65 years old[J]. Semergen,2017,43(6):425-436. DOI:10.1016/j.semerg.2016.06.015.
[14]
ORCHARDJ,LIJ L,FREEDMANB,et al. Atrial fibrillation screen,management,and guideline-recommended therapy in the rural primary care setting:a cross-sectional study and cost-effectiveness analysis of eHealth tools to support all stages of screening[J]. J Am Heart Assoc,2020,9(18):e017080. DOI:10.1161/JAHA.120.017080.
[15]
LEER,MITTALS. Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder[J]. Heart Rhythm,2018,15(2):287-295. DOI:10.1016/j.hrthm.2017.09.009.
WOJSZELZ B,KASIUKIEWICZA,SWIETEKM,et al. CHA2DS2-VASc score can guide the screening of atrial fibrillation - cross-sectional study in a geriatric ward[J]. Clin Interv Aging,2019,14:879-887. DOI:10.2147/CIA.S206976.